Gene sequencing equipment maker PacBio plans to cut around 120 jobs and lower expenses due to fresh tariffs and reduced ...

Tariffs and federal research “uncertainty” are forcing a Peninsula company to lay off workers at headquarters and cut other ...

Bernstein analyst Eve Burstein lowered the firm’s price target on PacBio (PACB) to $1.50 from $2 and keeps an Outperform rating on the shares.

Shares of PacBio (PACB) traded nearly 20% higher on Wednesday after the company said it is executing a plan, including job ...

PacBio will hold its quarterly conference call on Thursday, May 8, 2025, at 4:30 p.m. Eastern Time to discuss its first ...

Rady study uses PacBio long-read sequencing for RFX3 variant in adolescent patient with autism, showcasing clinical genomics ...

A major new initiative was launched on Tuesday (15 April) by the Wellcome Sanger Institute in collaboration with Pacific ...

US sequencing firm PacBio (Nasdaq: PACB) is cutting jobs and reducing spending across its business as it braces for the financial impact of new global tariffs and growing uncertainty around federal ...

What Happened? A number of stocks jumped in the afternoon session after markets rallied sharply on news that President Trump ...

Pacific Biosciences is reducing both headcount and spending across its DNA sequencing business, in the face of escalating global tariffs and threats to federal biomedical research grants. | Looking to ...

Our preliminary revenue for the first quarter met our expectations despite impacts from ongoing uncertainty in NIH funding in the United States and broader economic headwinds affecting the industry.

A major new initiative, launched on 15 April, will map how gene activity shapes the immune system, and could help identify new therapeutic targets for conditions such as Inflammatory Bowel Disease ...